BRIEF-Niagen Bioscience Inc Q2 Net Income USD 963 Thousand
NAGE•Q2 sales below estimates
Aug 04 (Reuters) - Niagen Bioscience Inc Q2 sales USD 29.785 million vs. IBES estimate USD 30.7 million.
Related News
Douglas Emmett posts Q2 2026 earnings results package on website
DEI•
Horizon Technology Finance Q2 FY26 net investment income drops 60.3% to $7.4 million; revenue rises 2.1% to $25 million
HRZN•
Talos Energy swings to Q2 FY26 profit of USD 149.67 million; revenue rises to USD 664.81 million
TALO•
Freshworks Q2 FY26 swings to GAAP profit of USD 3.2 million; revenue rises 16% year over year to USD 237.4 million
FRSH•
SSR Mining Q2 FY26 net income from continuing operations rises to $137.01 million; revenue increases 9.46% to $443.8 million
SSRM•